Literature DB >> 214404

Circulating immune complexes in rats bearing chemically induced tumours. II. Characterization of sera from different stages of tumour growth.

K Höffken, M R Price, V E Moore, R W Baldwin.   

Abstract

Sera from rats bearing intraperitoneal implants of an aminoazo dye-induced hepatoma were fractionated by Sephadex G200 and DEAE-cellulose ion exchange column chromatography. Isolated fractions were examined for their capacity to bind [125I]C1q as a measure of immune complex levels, and for their ability to bind soluble tumour-specific antigen as well as to react with antigens expressed at the surface of viable hepatoma cells. Elevated levels of circulating immune complexes in unfractionated serum were directly detectable during early tumour development although, following serum fractionation, immune complexes were identified at both early and late stages of tumour growth. The present findings suggest that the detection of immune complexes in unfractionated samples of late tumour-bearer serum using a C1q-binding assay is masked by the increasing production of tumour-specific antibodies and by a shift from complement fixing to non-complement-fixing tumour-specific antibodies.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214404     DOI: 10.1002/ijc.2910220512

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization.

Authors:  J R Starkey; W C Davis; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

2.  Immunologic enhancement of experimental metastasis in the rat.

Authors:  J R Starkey; S S Ristow; T L McDonald; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.

Authors:  J F Tsai; J H Tsai; W Y Chang
Journal:  Gastroenterol Jpn       Date:  1990-06

4.  Immune complexes with antiglobulin activity in sera of Moloney sarcoma-bearing rats.

Authors:  J R Balint
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

5.  Demonstration of IgG Fc receptors on spermatozoa and their utilization for the detection of circulating immune complexes in human serum.

Authors:  S S Witkin; S K Shahani; S Gupta; R A Good; N K Day
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

6.  Estimation of Circulating Immune Complexes in patients with Oral Leukoplakia and Oral Submucous Fibrosis: A Case Control Study.

Authors:  Maheswari H; Eswaran M A; Srividhya S; Malavika R; Prabhu R; Geetha K R
Journal:  J Clin Diagn Res       Date:  2014-01-12

7.  Tumour markers with unknown functions in gynaecological neoplasia.

Authors:  M R Price; P J McLaughlin; R A Robins; R W Baldwin; D Vasey; E M Symonds
Journal:  Arch Gynecol       Date:  1980

8.  Circulating immune complexes and trace elements (Copper, Iron and Selenium) as markers in oral precancer and cancer : a randomised, controlled clinical trial.

Authors:  Sunali S Khanna; Freny R Karjodkar
Journal:  Head Face Med       Date:  2006-10-16       Impact factor: 2.151

9.  Circulating immune complexes in dogs with osteosarcoma.

Authors:  A Segal-Eiras; R A Robins; D Hannant; L N Owen; R W Baldwin
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

10.  Tumour-associated antigens reacting with cytotoxic antibodies in serum of hepatoma-bearing rats.

Authors:  P Lando; K Berzins; J Gabriel; P Larsson; P Perlmann
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.